These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 36560754)
1. Taiwan Bat Lyssavirus: In Vitro and In Vivo Assessment of the Ability of Rabies Vaccine-Derived Antibodies to Neutralise a Novel Lyssavirus. Shipley R; Wright E; Smith SP; Selden D; Fooks AR; Banyard AC Viruses; 2022 Dec; 14(12):. PubMed ID: 36560754 [TBL] [Abstract][Full Text] [Related]
2. Assessing Rabies Vaccine Protection against a Novel Lyssavirus, Kotalahti Bat Lyssavirus. Shipley R; Wright E; Lean FZX; Selden D; Horton DL; Fooks AR; Banyard AC Viruses; 2021 May; 13(5):. PubMed ID: 34065574 [TBL] [Abstract][Full Text] [Related]
3. Utilisation of Chimeric Lyssaviruses to Assess Vaccine Protection against Highly Divergent Lyssaviruses. Evans JS; Wu G; Selden D; Buczkowski H; Thorne L; Fooks AR; Banyard AC Viruses; 2018 Mar; 10(3):. PubMed ID: 29543715 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Taxonomic Characteristics of Matlo and Phala Bat Rabies-Related Lyssaviruses Identified in South Africa. Viljoen N; Weyer J; Coertse J; Markotter W Viruses; 2023 Oct; 15(10):. PubMed ID: 37896824 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of rabies vaccines in dogs and cats and protection in a mouse model against European bat lyssavirus type 2. Nokireki T; Jakava-Viljanen M; Virtala AM; Sihvonen L Acta Vet Scand; 2017 Oct; 59(1):64. PubMed ID: 28969696 [TBL] [Abstract][Full Text] [Related]
6. Cross-Protection of Inactivated Rabies Vaccines for Veterinary Use against Bat Lyssaviruses Occurring in Europe. Servat A; Wasniewski M; Cliquet F Viruses; 2019 Oct; 11(10):. PubMed ID: 31614675 [TBL] [Abstract][Full Text] [Related]
7. Isolation and Characterization of Cross-Reactive Human Monoclonal Antibodies That Potently Neutralize Australian Bat Lyssavirus Variants and Other Phylogroup 1 Lyssaviruses. Weir DL; Coggins SA; Vu BK; Coertse J; Yan L; Smith IL; Laing ED; Markotter W; Broder CC; Schaefer BC Viruses; 2021 Mar; 13(3):. PubMed ID: 33804519 [TBL] [Abstract][Full Text] [Related]
8. Ability of rabies vaccine strains to elicit cross-neutralising antibodies. Brookes SM; Healy DM; Fooks AR Dev Biol (Basel); 2006; 125():185-93. PubMed ID: 16878476 [TBL] [Abstract][Full Text] [Related]
9. Genetic and Antigenetic Characterization of the Novel Kotalahti Bat Lyssavirus (KBLV). Calvelage S; Tammiranta N; Nokireki T; Gadd T; Eggerbauer E; Zaeck LM; Potratz M; Wylezich C; Höper D; Müller T; Finke S; Freuling CM Viruses; 2021 Jan; 13(1):. PubMed ID: 33419096 [TBL] [Abstract][Full Text] [Related]
10. Antigenic site changes in the rabies virus glycoprotein dictates functionality and neutralizing capability against divergent lyssaviruses. Evans JS; Selden D; Wu G; Wright E; Horton DL; Fooks AR; Banyard AC J Gen Virol; 2018 Feb; 99(2):169-180. PubMed ID: 29300155 [TBL] [Abstract][Full Text] [Related]
11. Novel Bat Lyssaviruses Identified by Nationwide Passive Surveillance in Taiwan, 2018-2021. Hu SC; Hsu CL; Lee F; Tu YC; Chen YW; Chang JC; Hsu WC Viruses; 2022 Jul; 14(7):. PubMed ID: 35891542 [TBL] [Abstract][Full Text] [Related]
12. Isolation, antigenicity and immunogenicity of Lleida bat lyssavirus. Banyard AC; Selden D; Wu G; Thorne L; Jennings D; Marston D; Finke S; Freuling CM; Müller T; Echevarría JE; Fooks AR J Gen Virol; 2018 Dec; 99(12):1590-1599. PubMed ID: 29745870 [TBL] [Abstract][Full Text] [Related]
13. Cross reactive antigenicity in orally vaccinated foxes and raccoon dogs against European Bat Lyssavirus type 1 and 2. Müller T; Selhorst T; Burow J; Schameitat A; Vos A Dev Biol (Basel); 2006; 125():195-204. PubMed ID: 16878477 [TBL] [Abstract][Full Text] [Related]
14. Toward the Development of a Pan-Lyssavirus Vaccine. Ben Hamed S; Myers JF; Chandwani A; Wirblich C; Kurup D; Paran N; Schnell MJ Viruses; 2024 Jul; 16(7):. PubMed ID: 39066269 [TBL] [Abstract][Full Text] [Related]
15. Current Rabies Vaccines Do Not Confer Protective Immunity against Divergent Lyssaviruses Circulating in Europe. Echevarría JE; Banyard AC; McElhinney LM; Fooks AR Viruses; 2019 Sep; 11(10):. PubMed ID: 31554170 [TBL] [Abstract][Full Text] [Related]
16. Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses. Brookes SM; Parsons G; Johnson N; McElhinney LM; Fooks AR Vaccine; 2005 Jul; 23(32):4101-9. PubMed ID: 15964478 [TBL] [Abstract][Full Text] [Related]
17. Serological Evidence of Lyssavirus Infection among Bats in Nagaland, a North-Eastern State in India. Mani RS; Dovih DP; Ashwini MA; Chattopadhyay B; Harsha PK; Garg KM; Sudarshan S; Puttaswamaiah R; Ramakrishnan U; Madhusudana SN Epidemiol Infect; 2017 Jun; 145(8):1635-1641. PubMed ID: 28228179 [TBL] [Abstract][Full Text] [Related]
18. Serological Evidence of Lyssaviruses among Bats on Southwestern Indian Ocean Islands. Mélade J; McCulloch S; Ramasindrazana B; Lagadec E; Turpin M; Pascalis H; Goodman SM; Markotter W; Dellagi K PLoS One; 2016; 11(8):e0160553. PubMed ID: 27501458 [TBL] [Abstract][Full Text] [Related]
19. Cross-neutralization of antibodies induced by vaccination with Purified Chick Embryo Cell Vaccine (PCECV) against different Lyssavirus species. Malerczyk C; Freuling C; Gniel D; Giesen A; Selhorst T; Müller T Hum Vaccin Immunother; 2014; 10(10):2799-804. PubMed ID: 25483634 [TBL] [Abstract][Full Text] [Related]
20. Favourable outcome in a patient bitten by a rabid bat infected with the European bat lyssavirus-1. Van Gucht S; Verlinde R; Colyn J; Vanderpas J; Vanhoof R; Roels S; Francart A; Brochier B; Suin V Acta Clin Belg; 2013; 68(1):54-8. PubMed ID: 23627196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]